. He can be reached at nsaraceno@mjhlifesciences.com.

Videos

Krenar Komoni, founder and CEO of Tive, highlights the transition in pharma from passive to real-time temperature control, noting delays in technology adoption but emphasizing how AI and automation will soon drive cost savings, improved quality, and stronger customer experience.

LogiPharma USA 2025: Challenges Currently Impacting the Temperature-Controlled Space

In the third part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, explains that as pharma quality systems evolve, AI is shifting from reactive problem-solving to proactive, closed-loop risk prevention, enhancing operator insight, decision-making, and continuous process improvement.

AI’s Next Step in Pharma Quality: From Detection to Closed-Loop Prevention

Ammie McAsey, SVP of Supply Chain Operations, McKesson, explains the critical role of real-time visibility, digital tools, and cold chain innovation in ensuring product quality, reducing disruptions, and strengthening patient care.

LogiPharma USA 2025: The Value of Visibility, Technology, and Trust

In the second part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, notes that nearly all pharma organizations are experimenting with AI to address labor shortages, data challenges, and regulatory demands, but full-scale adoption remains on the horizon as companies balance innovation with compliance.

Pharma Accelerates AI Adoption as Transparency and Traceability Take Center Stage

Krenar Komoni, founder and CEO of Tive, explains how the pharmaceutical industry’s transition from passive to real-time temperature control creates short-term challenges but will ultimately enable AI-driven automation, lower costs, higher quality, and better customer experiences.

LogiPharma USA 2025: How the Pharmaceutical Industry Collaborates to Boost Resilience Across the Global Supply Network

As precision medicine reshapes drug distribution, Ammie McAsey, SVP of Supply Chain Operations, McKesson, highlights the need for deeper investments in technology, temperature control, and end-to-end visibility to ensure quality and patient safety in advanced therapy supply chains.

LogiPharma USA 2025: Advanced Therapies Push Pharma Supply Chains Beyond Speed 

As AI adoption accelerates across life sciences, Shawn Opatka, VP and GM of Honeywell Life Sciences, and Linda Malek, partner at Crowell & Moring, discuss how regulatory expectations and federal initiatives—like the White House AI Action Plan—are shaping the technology’s future role in pharma quality, traceability, and healthcare systems.

Pharma’s AI Evolution: Balancing Innovation, Transparency, and Regulation

In a recent panel discussion, Krenar Komoni, founder and CEO of Tive, highlighted how combating rising supply chain theft requires a multi-layered, technology-driven security strategy. 

LogiPharma USA 2025: Pharmaceutical Supply Chain Security

Ammie McAsey, SVP of Supply Chain Operations, McKesson, emphasizes the critical role of collaboration, technology, and partnerships in ensuring advanced and specialty therapies reach patients safely and effectively.

LogiPharma USA 2025: Collaboration Takes Center Stage in Specialty Therapy Supply Chains

Dave Malenfant, healthcare supply chain expert, outlines the topics that are top of mind at the show.